Commercial Lab

Assessment workbench

Deterministic, transparent arithmetic. No discounting or NPV. Inputs are saved only in this browser.

Demo opportunity

View opportunity →Illustrative demo data

Inputs

Current baseline (annual £)

The measured current cost or income this changes.

Potential gross annual benefit (£)

Additional annual costs (£)

Incremental running costs caused by the change.

Initial investment (£)

Benefit starts (months from now)

Implementation probability 35%

Benefit type (cashability)

Prevents a future cost rising; does not release existing budget.

Results

Cost avoidance · not cashable by itselfNot finance validated

Net annual benefit

£300k

gross − additional annual costs

First-year estimate (prorated)

£0

net × 0/12 months of benefit

Probability-weighted net annual

£105k

net × 35% — a risk view, not a forecast

Simple payback

0.2 yrs

investment ÷ net; ~month 16 incl. start delay

This benefit type does not release budget by itself; do not count it as a cashable saving.
No baseline entered — benefits cannot be evidenced without a baseline.
Benefit starts after year one; first-year estimate is zero.

Assumptions: benefits and costs are flat each year and begin together at the start month; investment is spent upfront; no inflation, discounting, tax or financing costs. Results are illustrative arithmetic, not a business case or approval.

Investment Challenge

NOT FINANCE VALIDATED

For invest-to-save, every item needs evidence. Ticking items records self-assessment only; it is not approval or legal clearance.

Baseline is measured, not estimated
Alternatives (incl. do-nothing) were compared
All costs counted: staff, systems, exit, overheads
Cashable savings tied to a specific budget line
Risks and dependencies identified with owners
Milestones and benefit measurement defined
Budget owner named and has agreed
Stop/go gates set before full commitment

0 of 8 self-assessed